Keywords: duramed, 3rd, quarter, results, achieved, revenues, third
Duramed 3rd quarter results
Article | 27 November 1995
- Duramed achieved revenues in the 1995 third quarter of $13.1 million, up 13.9%. In the nine-month period they were $38.8 million, ahead 14.4%. Quarterly net ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
